New migraine drugs less efficacious than some triptans: BMJ review
However, neurologist Dr Bronwyn Jenkins says the new treatments are vital for certain patients.
Some triptans are more efficacious for acute migraines than newer, more expensive drugs including gepants, a review of 137 randomised controlled trials suggests.
Writing in The BMJ last week, the University of Oxford researchers say the top-performing triptans should be considered the treatment of choice for migraine episodes.
